Ash Biomedical Diagnostics Ltd has confirmed that all diagnostic products in its current portfolio hold valid registration with the National Agency for Food and Drug Administration and Control (NAFDAC), in full compliance with Nigeria’s national regulatory framework for medical devices and in-vitro diagnostics.
This confirmation comes at a time of heightened scrutiny across the sector, following NAFDAC’s March 2026 public alert flagging quality concerns around certain imported diagnostic kits from non-compliant manufacturers. Ash Biomedical’s products meet the applicable quality, safety, and performance standards required for supply to hospitals, clinics, government health programmes, and donor-funded procurement channels — and the company remains committed to sourcing only from manufacturers with verified regulatory standing.